9 Jefferies Group Apellis Pharmaceuticals Trades
Jefferies Group acquired 578k Apellis Pharmaceuticals shares worth $16.6M. That's 0.28% of their equity portfolio (70th largest holding). The first Apellis Pharmaceuticals trade was made in Q1 2023. Since then Jefferies Group bought shares five more times and sold shares on three occasions. The investor's estimated purchase price is $18.3M, resulting in a loss of 9.7%.
News about Apellis Pharmaceuticals Inc and Jefferies Group
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $90.00
Apellis Pharmaceuticals (NASDAQ:APLS ¨C Free Report) had its price target raised by The Goldman Sachs Group from $65.00 to $90.00 in a report released on Tues...
Russell Investments Group Ltd. Grows Stock Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Russell Investments Group Ltd. grew its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS ¨C Free Report) by 92.3% in the 1st quarter, accordin...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Shares Acquired by Macquarie Group Ltd.
Macquarie Group Ltd. lifted its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS ¨C Get Rating) by 2.8% during the fourth quarter, Holdings Ch...
Jefferies Financial Group Downgrades Apellis Pharmaceuticals to Hold
Apellis Pharmaceuticals was downgraded by stock analysts at Jefferies Financial Group from a ¡°buy¡± rating to a ¡°hold¡± rating in a research report issued on T...